These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 3363940

  • 21. [Leukemia and other neoplasms in patients with multiple myeloma].
    Kraj M, Pogłód R, Maj S.
    Nowotwory; 1985; 35(1):64-73. PubMed ID: 3862075
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia.
    Ataergin S, Arpaci F, Kaya A, Cetin T, Gunhan O.
    Am J Hematol; 2006 Dec; 81(12):987-8. PubMed ID: 16888783
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Comparison of sizes and shapes of tumor cells in plasma cell leukemia and plasma cell myeloma.
    Isobe T, Ikeda Y, Ohta H.
    Blood; 1979 May; 53(5):1028-30. PubMed ID: 435639
    [Abstract] [Full Text] [Related]

  • 29. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
    Xu K, Nacheva E.
    J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature.
    Alexandrescu DT, Koulova L, Wiernik PH.
    Clin Exp Dermatol; 2005 Jul; 30(4):391-4. PubMed ID: 15953079
    [Abstract] [Full Text] [Related]

  • 33. Plasmablastic cytomorphologic features in plasma cell neoplasms in immunocompetent patients are significantly associated with EBV.
    Chang ST, Liao YL, Lu CL, Chuang SS, Li CY.
    Am J Clin Pathol; 2007 Aug; 128(2):339-44. PubMed ID: 17638671
    [Abstract] [Full Text] [Related]

  • 34. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A, Tabernero MD, Sánchez ML, Pérez de Andrés M, Martín Ayuso M, Hernández J, Moro MJ, Fernández-Calvo J, Sayagués JM, Bortoluci A, San Miguel JF, Orfao A.
    Cancer; 2003 Feb 01; 97(3):601-9. PubMed ID: 12548602
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of bone marrow T cells in monoclonal gammopathy of undetermined significance, multiple myeloma, and plasma cell leukemia demonstrates increased infiltration by cytotoxic/Th1 T cells demonstrating a squed TCR-Vbeta repertoire.
    Pérez-Andres M, Almeida J, Martin-Ayuso M, Moro MJ, Martin-Nuñez G, Galende J, Hernandez J, Mateo G, San Miguel JF, Orfao A, Spanish Network on Multiple Myeloma, Spanish Network of Cancer Research Centers.
    Cancer; 2006 Mar 15; 106(6):1296-305. PubMed ID: 16475149
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.